References
- van Cauwenberge P, Verschraegen G, von Renterghem L. Bacteriological findings in sinusitis (1963-1975). Scand J Infect Dis 1976; Suppl 9: 72–7
- Lundberg C, Carenfelt C, Engquist S, Nord C E. Anaerobic bacteria in maxillary sinusitis. Scand J Infect Dis 1979; Suppl 19: 74–6
- Scheld W M, Sydnor A, Jr., Farr B, Gratz J C, Gwaltney J M., Jr. Comparison of cyclacillin and amoxicillin for therapy of acute maxillary sinusitis. Antimicrobiol Agents Chemother 1986; 30: 350–3
- Berg O, Carenfelt C, Kronvall G. Bacteriology of maxillary sinusitis in relation to character of inflammation and to prior treatment. Scand J Infect Dis 1988; 20: 511–6
- Wald E R, Milmoe G J, Bowen A, Ledesma-Medina J, Salamon N, Bluestone C D. Acute maxillary sinusitis in children. N Engl J Med 1981; 304: 749–54
- Doern G V. Branhamella catarrhalis–an emerging human pathogen. Diagn Microbiol Infect Dis 1986; 4: 191–201
- Jousimies-Somer H R, Savolainen S, Ylikoski J S. Bacteriological findings of acute auxiliary sinusitis in yound adults. J Clin Microbiol 1988; 26: 1919–25
- Karma P, Jokipii L, Sipilä P, Luotonen J, Jokipii A MM. Bacteria in chronic maxillary sinusitis. Arch Otolaryngol 1979; 105: 386–90
- Kallings I, Bengtsson S, Christiansen P, Holm S E, Lind L, Kalin M. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Scand J Infect Dis 1983; Suppl 39: 100–5
- Lundberg C, Nord C E. Microbiology and antibiotic treatment of paranasal sinus infections. Treatment of ear, nose, and throat infections. Workshop, National Board of Health and Welfare. 1985; 1: 51–62
- Ringertz S, Kronvall G. Increased use of erythromycin causes resistance in Haemophilus influenzae. Scand J Infect Dis 1987; 19: 247–56
- Freijd A, Rynnel-Dagö B. Isolation of nasopharyngeal B-lactamase producing H influenzae in relation to antibiotic treatment of acute otitis media in infants. Acta Otolaryngol (Stockh) 1983; 95: 351–7
- Bauernfeind A. A new generation of oral cephalosporins: Cefixime (FK027) in vitro activity against isolates from West Germany. A review of new oral cephems. Proceedings of a Workshop held at the 14th ICC, Japan, 1985
- Kamimura T, Kojo H, Matsumoto Y, Mine Y, Goto S, Kuwahara S. In vitro and in vivo antibacterial properties of FK-027, a new orally active cephem antibiotic. Antimicrob Agents Chemother 1984; 25: 95–104
- Kinoshita H, Baba S, Mori Y, et al. Laboratory and clinical studies on cefixime in otorhinolaryn-gological field. Chemotherapy (Tokyo) 1985; 33: 817–27
- Blackwelder W C. Controlled Clin Trials 1982; 3: 345–53
- Carenfelt C. Antral aspiration. Acta Otolaryngol (Stockh) 1982; 93: 237–41
- Berg O. Etiological diagnosis in sinusitis. Thesis, Karolinska Inst., Stockholm 1988
- Carenfelt C, Berg O, Bergstedt H, Lind M G, Perols O. discrimination of purulent from nonpurulent maxillary sinusitis Clinical and radiographic diagnosis. Ann Otol Rhinol Laryngol 1981; 90: 272–5
- Axelsson A, Brorson J E. The correlation between bacteriological findings in the nose and maxillary sinus in acute maxillary sinusitis. Laryngoscope 1973; 83: 2003–11
- Brorson J E, Larsson P, Zackrisson G. Antibiotic susceptibility of bacteria commonly isolated from upper respiratory tract. Infection 1983; 11: 287–8
- Nord C E. Efficacy of penicillin treatment in purulent maxillary sinusitis. A European multicenter trial. Infection 1988; 16: 209–14
- Hemlin C, Brauner A, Carenfelt C, Wretlind B. Nasopharyngeal culture with quantitative analysis of pathogens in chronic otitis media with effusion. Effects on pathogen yield of different swabs and transport methods. AMPIS 1989; 97: 606–10
- Nord C E, Movin G, Stahlberg D. Impact of cefixime on the normal intestinal microflora. Scand J Infect dis 1988; 20: 547–52